Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Care Excellence Single Technology Appraisal
Crossref DOI link: https://doi.org/10.1007/s40273-017-0568-3
Published Online: 2017-09-15
Published Print: 2018-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tikhonova, Irina A.
Jones-Hughes, Tracey
Dunham, James
Warren, Fiona C.
Robinson, Sophie
Stephens, Peter
Hoyle, Martin
Funding for this research was provided by:
Health Technology Assessment Programme (16/54/11)
License valid from 2017-09-15